RECURRENT OROPHARYNGEAL CARCINOMA
Clinical trials for RECURRENT OROPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OROPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT OROPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Pill combo could offer new hope for rural head and neck cancer patients
Disease control Recruiting nowThis study is testing whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for people with head and neck cancer that has come back or spread. The trial focuses on patients in rural Midwest areas, aiming to make treatment more acc…
Matched conditions: RECURRENT OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
Double vaccine attack: new hope for HPV-Positive throat cancer?
Disease control Recruiting nowThis study tests whether giving two different HPV vaccines along with the immunotherapy drug pembrolizumab can help shrink or control advanced throat cancer that has spread or come back. The trial enrolls 54 adults with HPV-positive oropharyngeal cancer whose tumors have a specif…
Matched conditions: RECURRENT OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Michael K. Gibson • Aim: Disease control
Last updated May 18, 2026 12:00 UTC